Fig. 2
Treatment related adverse events. (A) All patients in the study; (B) Patients treated with PD-1 inhibitor alone and patients with PD-1 inhibitor plus chemotherapy, respectively
Fig. 2 | BMC Urology
Treatment related adverse events. (A) All patients in the study; (B) Patients treated with PD-1 inhibitor alone and patients with PD-1 inhibitor plus chemotherapy, respectively